Investment Advisory Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
+2,034
New +$182K 0.05% 211
2024
Q2
Sell
-3,527
Closed -$281K 166
2024
Q1
$281K Buy
3,527
+10
+0.3% +$764 0.12% 123
2023
Q4
$278K Hold
3,517
0.13% 114
2023
Q3
$246K Buy
3,517
+37
+1% +$2.62K 0.13% 113
2023
Q2
$241K Sell
3,480
-122
-3% -$8.68K 0.12% 121
2023
Q1
$268K Buy
3,602
+1,000
+38% +$83.9K 0.15% 111
2022
Q4
$242K Buy
2,602
+1
+0% +$96 0.15% 117
2022
Q3
$248K Hold
2,601
0.17% 101
2022
Q2
$241K Sell
2,601
-200
-7% -$19.5K 0.16% 105
2022
Q1
$283K Hold
2,801
0.17% 100
2021
Q4
$295K Buy
+2,801
New +$259K 0.19% 95

Other funds holding CVS

Investment Advisory Group's CVS Position: Q2 2026 in Review

Investment Advisory Group opened a new position in CVS Health (CVS) in Q2 2026: 2,034 shares worth $210K. The stake represents 0.05% of the portfolio and ranks #211 among its holdings. This is a return to the name: Investment Advisory Group previously reported a position in CVS as recently as Q1 2024.

Investment Advisory Group first reported a position in CVS in Q4 2021 and has held it in 11 quarters since. The position peaked at $295K in Q4 2021. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Investment Advisory Group held 2,034 shares of CVS Health worth $210K as of Q2 2026.
  • CVS Health was a new Investment Advisory Group position in Q2 2026.
  • CVS Health made up 0.05% of Investment Advisory Group's portfolio in Q2 2026, its #211 holding.
  • Investment Advisory Group first reported a position in CVS Health in Q4 2021 and has held it in 11 quarters since.
  • Investment Advisory Group's CVS Health position peaked at $295K in Q4 2021.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Investment Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.